| 994 |
Centers for Disease Control and Prevention |
Html |
en |
Archived Spotlights - News - Vaccines |
Vaccine Archived Spotlights |
| CIINC registration | 0.6877 |
| Oct | 0.591058 |
| Herpes Zoster Vaccines | 0.565921 |
| HPV Cancer Prevention | 0.564415 |
| ACIP flu vaccine | 0.521189 |
| United States | 0.517876 |
| adult vaccination coverage | 0.570947 |
| Book chapter Polio | 0.508975 |
| HPV | 0.616681 |
| New HPV resource | 0.580352 |
| vaccination coverage | 0.975038 |
| Tdap module | 0.560506 |
| New webinar recast | 0.527727 |
| Shots | 0.670149 |
| Rotavirus module | 0.51451 |
| vaccination information | 0.511093 |
| Adult Immunization Schedules | 0.763034 |
| New site | 0.580853 |
| National Vaccine Plan | 0.50961 |
| (Apr 21) | 0.488989 |
| MMWR | 0.506645 |
| ppsv23 vaccines | 0.520484 |
| Health Information Award | 0.517197 |
|
| module | 0.634144 |
| Shots training | 0.543503 |
| CIINC session | 0.512641 |
| Children Aged | 0.514313 |
| hpv vaccination | 0.60738 |
| Flu module | 0.506163 |
| Child Vaccines | 0.50437 |
| Influenza module | 0.521493 |
| live influenza vaccines | 0.529323 |
| HPV Partner Toolkit | 0.569856 |
| HPV VISs | 0.520679 |
| Polio module | 0.508457 |
| Pink Book | 0.519142 |
| HPV Vaccination Coverage | 0.60648 |
| Meningococcal module | 0.51289 |
| Pneumococcal module | 0.510458 |
| Webinar registration | 0.616034 |
| Hepatitis B module | 0.519787 |
| DTaP module | 0.503456 |
| Pink Book webinars | 0.512864 |
| HPV module | 0.595954 |
| Varicella module | 0.517836 |
| VFC module | 0.507883 |
|
CLICK HERE |
| 5069 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, November 01, 2009 |
null |
| human metapneumovirus subtypes | 0.673631 |
| Oct | 0.695529 |
| inspiratory pressure tests | 0.678056 |
| Baron SL | 0.674297 |
| diabetic retinopathy prevalence | 0.675273 |
| primary care physician | 0.674269 |
| National Birth Defects | 0.822372 |
| Cancer screening practices | 0.676103 |
| New York City | 0.673416 |
| California health interview | 0.687129 |
| Crider KS | 0.674689 |
| CDC Knowledge | 0.711359 |
| Action Science Clips | 0.927352 |
| new weekly digest | 0.678309 |
| bladder cancer risk | 0.685854 |
| quality control materials | 0.672958 |
| Chief Science Officer | 0.684183 |
| cervical cancer screening | 0.680238 |
| Clin Infect Dis. | 0.743305 |
| maximum inspiratory pressure | 0.726739 |
| recent sexual activity | 0.674139 |
| catalyze primary care | 0.67265 |
| Defects Prevention Study | 0.74557 |
| public health strategies | 0.719464 |
| randomized controlled study | 0.682227 |
|
| Stephen B. Thacker | 0.746181 |
| Health Educ Behav. | 0.696808 |
| United States | 0.755837 |
| plasma glucose levels | 0.677403 |
| public health advocate | 0.697543 |
| 22-year follow-up study | 0.676606 |
| sexual risk behavior | 0.684968 |
| cardiovascular risk reduction | 0.684787 |
| public health | 0.772943 |
| breast cancer risk | 0.702165 |
| diabetes diagnostic thresholds | 0.673997 |
| vaccine safety monitoring | 0.670704 |
| national asthma survey | 0.68463 |
| public health literature | 0.697205 |
| B. Thacker CDC | 0.774748 |
| electronic health records | 0.683546 |
| Birth Defects Prevention | 0.74558 |
| U.S. population | 0.675482 |
| inspiratory pressure reference | 0.678031 |
| school-based sealant programs | 0.672905 |
| et al | 0.691894 |
| in-home care workers | 0.681974 |
| lay health advisors | 0.698035 |
| Thacker CDC Library | 0.774736 |
|
CLICK HERE |
| 6513 |
Centers for Disease Control and Prevention |
Html |
en |
Additional Specimen Collection for Detection of Influenza A (H3N2) Variant Virus Infections |
Interim Guidance for Enhanced Influenza Surveillance: Additional Specimen Collection for Detection of Influenza A (H3N2) Variant Virus Infections - CDC |
| school settings | 0.702464 |
| limited serologic studies | 0.675564 |
| ILI | 0.813841 |
| high priority areas | 0.643396 |
| seasonal influenza viruses | 0.825998 |
| person-to-person transmission | 0.843885 |
| Real-Time rRT-PCR FLU | 0.656677 |
| enhanced surveillance guidance | 0.745078 |
| reverse-transcription polymerase chain | 0.713641 |
| Influenza A Subtyping | 0.710279 |
| sustained community-wide transmission | 0.71413 |
| new information | 0.687269 |
| low levels | 0.535429 |
| CDC Influenza Division | 0.87633 |
| RT-PCR testing | 0.615887 |
| virus subtypes | 0.56865 |
| agricultural fair season | 0.704326 |
| contact tracing | 0.634568 |
| additional testing | 0.55757 |
| timely detection | 0.542865 |
| surveillance diagnostic testing | 0.690475 |
| Detected U.S. Human | 0.693022 |
| severe presentations | 0.562886 |
| influenza A H3N2 | 0.836663 |
| influenza surveillance | 0.831839 |
|
| public health laboratories | 0.892748 |
| CDC Human Influenza | 0.888958 |
| Case Count | 0.550816 |
| influenza | 0.944516 |
| infect swine | 0.575906 |
| recent swine contact | 0.723778 |
| agricultural fair attendance | 0.698031 |
| H3N2 virus | 0.572041 |
| United States | 0.557483 |
| potential person-to-person transmission | 0.727389 |
| H3N2v cases | 0.677692 |
| influenza-like illness | 0.538404 |
| interim guidance | 0.565188 |
| ILINet providers | 0.56858 |
| primer/probe sets | 0.540996 |
| child care | 0.539887 |
| local health departments | 0.902151 |
| variant influenza | 0.732701 |
| person-to-person H3N2v virus | 0.816205 |
| rRT-PCR testing | 0.551341 |
| specimens | 0.79452 |
| InfA-positive specimens | 0.646403 |
| human infections | 0.663694 |
| influenza testing | 0.731141 |
|
CLICK HERE |
| 6576 |
Centers for Disease Control and Prevention |
Html |
null |
Health Effects of Exposure to Substances and Carcinogens |
ATSDR - Health Effects,Cancer, Organ Systems, carcinogens |
|
|
CLICK HERE |
| 8179 |
Centers for Disease Control and Prevention |
Html |
en |
Muscular Dystrophy - Free Materials |
null |
| Becker muscular dystrophy | 0.539341 |
| Becker Muscular Dystrophies | 0.467862 |
| physical therapists | 0.32646 |
| Duchenne Muscular Dystrophy-A | 0.470297 |
| CDC | 0.305911 |
| American Medical Association | 0.346731 |
| JAMA Patient Page | 0.346776 |
| students | 0.305077 |
| oculopharyngeal muscular dystrophies | 0.47624 |
| family-friendly clinical care | 0.349091 |
| Information | 0.317341 |
| life | 0.305714 |
| limb-girdle muscular dystrophy | 0.568476 |
| congenital muscular dystrophy | 0.587692 |
| muscular dystrophy | 0.92485 |
| Public Health Challenge | 0.356137 |
| fact sheet | 0.416316 |
| ways | 0.30573 |
| facioscapulohumeral muscular dystrophy | 0.740323 |
| Girdle Muscular Dystrophies | 0.471423 |
| fact sheet outlines | 0.34471 |
| teachers | 0.305092 |
|
| Diagnosis | 0.304955 |
| Duchenne Muscular Dystrophy | 0.552941 |
| muscular dystrophies | 0.515055 |
| Schools | 0.305121 |
| guide | 0.321297 |
| school personnel | 0.328124 |
| overview | 0.309974 |
| patients | 0.305002 |
| FSHD | 0.307454 |
| Rare Muscular Dystrophies | 0.479707 |
| families | 0.324281 |
| people | 0.30571 |
| Muscular Dystrophy Association | 0.67291 |
| limb-girdle muscular dystrophies | 0.47829 |
| individualized plan | 0.328008 |
| Facts | 0.320068 |
| quality | 0.305718 |
| myotonic muscular dystrophy | 0.561893 |
| Researchers | 0.305743 |
| Physical Therapy | 0.327704 |
| distal muscular dystrophy | 0.586986 |
|
CLICK HERE |
| 8894 |
Centers for Disease Control and Prevention |
Html |
en |
Malaria - Malaria Worldwide |
Information on global malaria programs, malaria's impact, and how to reduce malaria's impact in the world as well as CDC's global activities. |
| decade | 0.426025 |
| malaria—most | 0.42474 |
| CDC | 0.512676 |
| numbers | 0.424456 |
| individuals | 0.421292 |
| vulnerable groups | 0.529665 |
| pregnant women | 0.52663 |
| weak infrastructure | 0.519809 |
| control interventions | 0.522064 |
| young children | 0.660784 |
| lives | 0.422921 |
| pregnancy | 0.421509 |
| scale-up | 0.475395 |
| malaria control efforts | 0.855948 |
| deadly species | 0.521528 |
| high transmission | 0.51937 |
| poor countries | 0.516716 |
| global support | 0.513665 |
| eradication | 0.42754 |
| plans | 0.422819 |
| malaria landscape | 0.68508 |
| technical expertise | 0.642552 |
| malaria-endemic countries | 0.627462 |
| high intervention costs | 0.611654 |
| efficient mosquito | 0.520729 |
|
| death | 0.421918 |
| malaria mortality | 0.727765 |
| immunity | 0.455313 |
| malaria | 0.99729 |
| largest burden | 0.527507 |
| policy development | 0.519047 |
| sub-Saharan Africa | 0.545327 |
| world | 0.422455 |
| program guidance | 0.516062 |
| hopes | 0.424988 |
| collaborative work | 0.527415 |
| elimination | 0.425307 |
| subtropical areas | 0.533594 |
| Roll Back Malaria | 0.689435 |
| national commitment | 0.516748 |
| scientific research | 0.51534 |
| long history | 0.514765 |
| resources | 0.424425 |
| high prevalence | 0.520412 |
| families | 0.421278 |
| people | 0.424763 |
| parasite | 0.422406 |
| partners | 0.444962 |
| favorable climate | 0.52016 |
|
CLICK HERE |
| 9456 |
Centers for Disease Control and Prevention |
Html |
es |
Efectos de la percepción de las características del vecindario y del uso de las instalaciones comunitarias en la realización de actividad física en adultos con o sin discapacidades |
null |
| Human Services | 0.302605 |
| improving health | 0.30096 |
| Prev Chronic Dis | 0.304303 |
| Risk Factor Surveillance | 0.301642 |
| physical activity behaviors | 0.301282 |
| Mechelen W | 0.300841 |
| Prev Med | 0.30323 |
| Disease Control | 0.300759 |
| Ramsey LT | 0.300838 |
| US Census Bureau | 0.300584 |
| people with | 0.303333 |
| Phys Act Health | 0.301297 |
| with physical disabilities | 0.3025 |
| Am Behav Sci | 0.300836 |
| Factor Surveillance System | 0.301603 |
| perceived environmental characteristics | 0.300687 |
| Sociol Health Illn | 0.301153 |
| US Department | 0.302837 |
| among persons with | 0.300854 |
| Environmental health | 0.30102 |
| Rimmer JH | 0.303306 |
| Estados Unidos | 0.300842 |
| Gauvin L | 0.300809 |
| with disabilities | 0.305528 |
| actividad fÃsica | 0.996135 |
|
| shift from disability | 0.300603 |
| salud pública | 0.301715 |
| Phys Ther | 0.301184 |
| Behav Nutr Phys | 0.300672 |
| Behavioral Risk Factor | 0.301673 |
| form relationships with | 0.300758 |
| built environment | 0.301008 |
| chronic health conditions | 0.301154 |
| Jackson RJ | 0.300829 |
| among people with | 0.30089 |
| Health Promot | 0.321676 |
| pasos peatonales anchos | 0.300607 |
| public health | 0.302674 |
| Killingsworth R | 0.300924 |
| Powell KE | 0.30084 |
| Kriska AM | 0.300592 |
| systematic review | 0.300886 |
| Brownson RC | 0.300843 |
| Brodeur J | 0.300802 |
| physical activity | 0.318966 |
| siguientes instalaciones | 0.300952 |
| persons with disabilities | 0.302291 |
| Health Perspect | 0.300954 |
| with disabilities act | 0.301091 |
|
CLICK HERE |
| 12226 |
Centers for Disease Control and Prevention |
Html |
en |
Hand Foot and Mouth Disease | Overview of HFMD |
About hand, foot, and mouth disease: causes, signs and symptoms, diagnosis, treatment, prevention and complications. |
| MPEG | 0.343402 |
| viruses | 0.345358 |
| different file formats | 0.596455 |
| symptoms | 0.33893 |
| mouth disease | 0.989459 |
| signs | 0.339029 |
| PDF | 0.332008 |
|
| PPT | 0.355091 |
| DOC | 0.341556 |
| health care providers | 0.593979 |
| foot | 0.499873 |
| hand | 0.500402 |
| health complications | 0.479813 |
|
CLICK HERE |
| 13222 |
Centers for Disease Control and Prevention |
Video |
en |
Ebola: Getting to Zero |
Progress has been made in the year since CDC first responded to the Ebola outbreak in West Africa, but CDC’s and the world’s efforts must continue until there are zero new cases.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://www.cdc.gov/media/video/dpk/2015/dpk-getting-to-zero/GettingToZero-Long%20embedded.wmv |
|
|
CLICK HERE |
| 14217 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Measles Elimination - Nepal, 2007-2014 |MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| Measles Nucleotide Surveillance | 0.509598 |
| timely measles | 0.497153 |
| case-based surveillance sites | 0.416704 |
| Nepal National Measles | 0.514569 |
| national Health Management | 0.400528 |
| Case-based surveillance sensitivity | 0.406682 |
| measles elimination | 0.743214 |
| SEAR measles surveillance | 0.514676 |
| measles incidence | 0.589671 |
| measles laboratory network | 0.531547 |
| children | 0.424212 |
| routine immunization | 0.668768 |
| measles outbreaks | 0.553771 |
| measles vaccination coverage | 0.54247 |
| MCV1 coverage | 0.467531 |
| national public health | 0.401789 |
| fully immunized village | 0.453583 |
| routine immunization services | 0.6243 |
| large measles outbreaks | 0.495614 |
| reported measles | 0.509391 |
| World Health Organization | 0.494005 |
| health facilities | 0.43142 |
| low-performing measles | 0.499844 |
| measles susceptibility | 0.475703 |
| national routine immunization | 0.398934 |
|
| South-East Asia Region | 0.436411 |
| measles risk assessments | 0.492859 |
| measles elimination strategies | 0.538084 |
| national measles elimination | 0.57681 |
| quality measles surveillance | 0.522865 |
| measles surveillance | 0.554124 |
| measles case-based surveillance | 0.858978 |
| measles infection | 0.52181 |
| measles follow-up SIA | 0.488329 |
| clinically compatible cases | 0.440802 |
| districts | 0.419895 |
| measles cases | 0.659583 |
| annual suspected measles | 0.549383 |
| case-based surveillance | 0.920111 |
| VPD surveillance network | 0.449868 |
| measles elimination measures | 0.507069 |
| measles case data | 0.490379 |
| endemic measles cases | 0.54588 |
| case-based measles surveillance | 0.544795 |
| national case-based surveillance | 0.413287 |
| monovalent measles vaccine | 0.596806 |
| case-based surveillance performance | 0.463673 |
| routine immunization program | 0.523546 |
| measles cases††| 0.480741 |
|
CLICK HERE |